The Effect of Oksitosin Induction Management on Preeclampsia to the Hyperbilirubinemia Incidence : Case Report
DOI:
https://doi.org/10.35316/oksitosin.v12i2.6052Keywords:
neonatal hyperbilirubinemia, oksitosin induction, continuity of care, maternal complicationsAbstract
Around 3% of 120 million newborns experience neonatal jaundice Every year. It was estimated that the condition affects at least 481,000 babies and causes approximately 114,000 deaths globally. Case report: A 33-year-old woman P3A0 with pregnancy complications of preeclampsia gave birth to her 3rd child by oksitosin induction at 36/37 weeks gestational age. The mother has received continuity of midwife care since 22/23 weeks of pregnancy. On the 6th day after birth, the baby experienced Kramer IV neonatorum jaundice and it was then referred to the hospital. The results of total bilirubin examination at the hospital were 24 mg/dl. The parents received counseling by telehealth and home visits about on breast milk expressed, parent support, counseling parents regarding the nutritional and fluid adequacy of providing on-demand breast milk without formula milk mixture, personal hygiene, and thermoregulation. Conclusion: The management of pregnancy complications using oksitosin induction was considered to have an impact on neonatal outcomes, such as neonatal jaundice. So, it was recommended to do it carefully by considering the benefits compared to the risks. Because hyperbilirubinemia management aims to reduce morbidity, disability, and mortality.
Downloads
References
Akhavan, S. et al. (2016) ‘Oxytocin and neonatal hyperbilirubinemia: A cohort study’, Research Journal of Pharmaceutical, Biological and Chemical Sciences, 7(4), pp. 2098–2101.
Ansong-Assoku, B. et al. (2023) ‘Neonatal Jaundice’, Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring. StatPearls Publishing, 13(3), pp. 1–4.
Belay, G. et al. (2023) ‘Jaundice and its associated factors among neonates admitted to selected referral hospitals in southwest oromia, Ethiopia: Multi-center cross-sectional study’, Heliyon. Elsevier Ltd, 9(5), p. e16019. doi: 10.1016/j.heliyon.2023.e16019.
Boskabadi, H., Rakhshanizadeh, F. and Zakerihamidi, M. (2020) ‘Evaluation of maternal risk factors in neonatal hyperbilirubinemia’, Archives of Iranian Medicine, 23(2), pp. 128–140.
Brits, H. et al. (2018) ‘The prevalence of neonatal jaundice and risk factors in healthy term neonates at National District Hospital in Bloemfontein’, African Journal of Primary Health Care and Family Medicine, 10(1), pp. 1–6. doi: 10.4102/phcfm.v10i1.1582.
Chang, K. J., Seow, K. M. and Chen, K. H. (2023) ‘Preeclampsia: Recent Advances in Predicting, Preventing, and Managing the Maternal and Fetal Life-Threatening Condition’, International Journal of Environmental Research and Public Health, 20(4). doi: 10.3390/ijerph20042994.
Fanello, C. et al. (2023) ‘Prevalence and Risk Factors of Neonatal Hyperbilirubinemia in a Semi-Rural Area of the Democratic Republic of Congo: A Cohort Study’, American Journal of Tropical Medicine and Hygiene, 109(4), pp. 965–974. doi: 10.4269/ajtmh.23-0293.
Garosi, E., Mohammadi, F. and Ranjkesh, F. (2016) ‘The relationship between neonatal jaundice and maternal and neonatal factors’, Iranian Journal of Neonatology, 7(1), pp. 37–40.
Kementrian Kesehatan RI (2019) ‘Pedoman nasional pelayanan kedokteran tata laksana hiperbilirubinemia’, Kemenkes RI, pp. 1–154.
Kementerian Kesehatan RI, (2019). Laporan Nasional RKD 2018, Jakarta: Badan Penelitian dan Pengembangan kesehatan
Lueth, G. D., Kebede, A. and Medhanyie, A. A. (2020) ‘Prevalence, outcomes and associated factors of labour induction among women delivered at public hospitals of MEKELLE town-(a hospital based cross sectional study)’, BMC Pregnancy and Childbirth. BMC Pregnancy and Childbirth, 20(1), pp. 1–10. doi: 10.1186/s12884-020-02862-7.
Mani, M. et al. (2020) ‘Neonatal Hyperbilirubinemia Associated With Oxytocin Labour Augmentation’, IOSR Journal of Dental and Medical Sciences ( IOSR-JDMS), 19(3), pp. 1–6. doi: 10.9790/0853-1903030106.
Mosayebi, Z. et al. (2013) ‘Evaluation of Labouratory Disorders in Admitted Neonates in NICU Who Were Born to Preeclamptic Mothers’, Journal of Comprehensive Pediatrics, 4(4), pp. 194–9. doi: 10.17795/compreped-12755.
Pace, E. J., Brown, C. M. and DeGeorge, K. C. (2019) ‘Neonatal hyperbilirubinemia: An evidence-based approach’, Journal of Family Practice, 68(1), pp. E4–E11.
Queensland Clinical Guidelines (2022) ‘Maternity and Neonatal Clinical Guideline Neonatal’, Queensland Goverment, p. 23.
Sánchez-Redondo Sánchez-Gabriel, M. D. et al. (2017) ‘Guidelines for prevention, detection and management of hyperbilirubinaemia in newborns of 35 or more weeks of gestation’, Anales de Pediatria, 87(5), pp. 294.e1-294.e8. doi: 10.1016/j.anpedi.2017.03.006.
Seyedi, R., Mirghafourvand, M. and Tabrizi, S. O. (2017) ‘The effect of the use of oxytocin in labour on neonatal jaundice: A systematic review and meta-analysis’, International Journal of Pediatrics, 5(12), pp. 6541–6553. doi: 10.22038/ijp.2017.26526.2277.
Shahd A. Karrar; Peter L. Hong. (2023) ‘Pre-eclampsia: pathophysiology’, British Medical Journal- Best Practice, pp. 1–5.
WHO (2019) Survive & thrive (Transforming care for every small and sick newborn), Delicious Living.
World Health Organization (WHO) (2022) ‘Maternity and Neonatal Clinical Guidelinel’, World Health Organization.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Oksitosin : Jurnal Ilmiah Kebidanan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
